Peritubular capillary rarefaction: a new therapeutic target in chronic kidney disease. - Wikidata - wikimedia - TriplyDB

Peritubular capillary rarefaction: a new therapeutic target in chronic kidney disease.

Peritubular capillary rarefaction: a new therapeutic target in chronic kidney disease.

http://www.wikidata.org/entity/Q37053858

about

Efficacy and safety of eculizumab in atypical hemolytic uremic syndrome from 2-year extensions of phase 2 studies Fluorescence microangiography for quantitative assessment of peritubular capillary changes after AKI in mice Capillary rarefaction: an early marker of microvascular disease in young hemodialysis patients.Interstitial pericytes decrease in aged mouse kidneys.Retinal Capillary Rarefaction in Patients with Type 2 Diabetes Mellitus Impaired angiogenesis in the enalapril-treated neonatal rat kidney.What is damaging the kidney in lupus nephritis?Interferon gamma peptidomimetic targeted to interstitial myofibroblasts attenuates renal fibrosis after unilateral ureteral obstruction in mice.Cerebral neovascularization in diabetes: implications for stroke recovery and beyond.Renal allograft fibrosis: biology and therapeutic targets.Tubular atrophy in the pathogenesis of chronic kidney disease progression.Just Look! Intravital Microscopy as the Best Means to Study Kidney Cell Death Dynamics.Progression of chronic kidney disease: too much cellular talk causes damage.A perspective on chronic kidney disease progression.Endothelial sirtuin 1 inactivation enhances capillary rarefaction and fibrosis following kidney injury through Notch activation Angiopoietin-1 deficiency increases renal capillary rarefaction and tubulointerstitial fibrosis in mice.Contrast-enhanced CT imaging in patients with chronic kidney disease.Hypoxia Activates Src and Promotes Endocytosis Which Decreases MMP-2 Activity and Aggravates Renal Interstitial Fibrosis.Comparison of acute kidney injury of different aetiology reveals in-common mechanisms of tissue damage.Hypoxia paradoxically inhibits the angiogenic response of isolated vessel explants while inducing overexpression of vascular endothelial growth factor.Mitoprotection preserves the renal vasculature in porcine metabolic syndrome.Capillary rarefaction from the kidney point of view.

P2860

Q33420172-1C23BEA8-E91A-4CC8-96C1-E3FDF6660FFF Q34103499-B37C8423-4B77-4618-96A5-25AC1089836C Q35310636-075C4037-6945-4D7D-836B-219584A2313F Q35859758-A038E258-4DB7-4E81-95F5-DF0F0E0AC4C3 Q36217523-8533E20E-EF23-4CBD-BCB1-2B783732213A Q36578942-6C2E2EB6-B8E6-4FD0-9DAE-FD78C119008A Q36765221-E5B1FB72-A886-4703-9F29-201430BF7BE5 Q37688040-0E14968F-14EC-4B32-9C45-F9A666743A1F Q38185249-28DE64E1-BCF1-496A-A2C7-B86D4483A45D Q38359455-84D37632-B698-4671-B990-1E6AC388B531 Q38553671-3B512D18-B5F6-4217-8666-BC642F03D992 Q38875298-62F539F0-4D7E-4427-8DC5-34FA6BC148D4 Q38988806-4B081B6E-14D5-4491-9FD9-BF0AC7CE5B23 Q39038570-40BACC91-7BA9-45F6-A119-71B21E52D40C Q41081085-6D2FAC3F-0D2E-467E-A085-1DC054492173 Q48322032-C547F096-589D-420C-B11F-E1A17B226F15 Q48374957-C003900E-C278-41AB-B1D8-32A32F9B1B75 Q49805700-E049829B-7AD5-4122-B46C-3DB0A3D84B62 Q50003562-2826ABCD-D851-4B86-8F2E-98759B5F55F7 Q51557632-35270034-09D8-4AD5-AB6D-401803CD775C Q52715221-8D6CBEEA-3D16-4465-AD54-AC2D1C46C3E9 Q55483555-0B606837-FCCE-41FC-BC20-A66965F73393

P2860

Peritubular capillary rarefaction: a new therapeutic target in chronic kidney disease.

http://www.wikidata.org/entity/Q37053858

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 10 March 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Peritubular capillary rarefaction: a new therapeutic target in chronic kidney disease.

@en

Peritubular capillary rarefaction: a new therapeutic target in chronic kidney disease.

@nl

type

label

Peritubular capillary rarefaction: a new therapeutic target in chronic kidney disease.

@en

Peritubular capillary rarefaction: a new therapeutic target in chronic kidney disease.

@nl

prefLabel

Peritubular capillary rarefaction: a new therapeutic target in chronic kidney disease.

@en

Peritubular capillary rarefaction: a new therapeutic target in chronic kidney disease.

@nl

P1433

Q37053858-182B6A66-3128-4A8B-B68D-766CC0DA3CF9

P1476

Q37053858-8E27E434-1B9A-479F-87C8-1913EE72610E

P2093

Q37053858-18DF0312-7042-4778-8C00-FE4FE4B7258A

Q37053858-3B4CFF5F-D7B0-4ECC-98A7-7C4AE90C24C2

Q37053858-EAC7E28E-8BE2-4A6A-A5CF-1EF586A6D3C6

P2860

Q37053858-02EA6ACA-6B98-4C1B-838A-2149664F9185

Q37053858-07D049F4-067E-42F1-A68A-88E6423771C6

Q37053858-0D3BFD7B-044B-44BB-8051-D1685176938D

Q37053858-10D66F06-39D0-44C4-B84E-38E8CA8AAB91

Q37053858-115CFCF0-0F9F-49F7-AEDE-A218B3F6ACEA

Q37053858-12127F15-7194-422F-A09F-75DF60407661

Q37053858-13F2E770-C513-4B43-9089-261497A99A60

Q37053858-15C8EAF8-1D02-4525-82E1-5ADC8EEFD7B7

Q37053858-1EC04503-03A4-481D-BE02-1FA5494E7942

Q37053858-21CB7ACF-54D4-462D-9336-DFD438447233

P2888

Q37053858-E1A3CCDB-4F3C-4B2E-AC35-88AD4705AF6E

P304

Q37053858-CA1D9678-1655-43BC-A9B6-8EB98CFC4AF6

P31

Q37053858-7DE78492-F1D7-438C-AA08-6682D8469077

P356

Q37053858-266B2138-E8DD-4AF4-B379-DCA69C50B81F

P433

Q37053858-BCF2E83E-F636-487C-8D39-C89BEEF8F12A

P478

Q37053858-6F8F4CA9-BFFA-4199-BE99-CEB32A7C70F8

P577

Q37053858-561C1AA6-00F4-4854-905C-BDA3EF14E41E

P698

Q37053858-C1E853EB-1DC4-47BA-AC14-F98738709017

P932

Q37053858-982EE274-FC24-4C65-B36E-73EA90164F96

P356

S00467-013-2430-Y

P1433

Pediatric Nephrology

P1476

Peritubular capillary rarefaction: a new therapeutic target in chronic kidney disease.

@en

P2093

Bie Nga Tchao

http://www.w3.org/2001/XMLSchema#string

Ikuyo Yamaguchi

http://www.w3.org/2001/XMLSchema#string

Yujiro Kida

http://www.w3.org/2001/XMLSchema#string

P2860

Hypoxia promotes fibrogenesis in vivo via HIF-1 stimulation of epithelial-to-mesenchymal transition

Thrombospondin-1 inhibits endothelial cell responses to nitric oxide in a cGMP-dependent manner

Angiopoietin-1 is essential in mouse vasculature during development and in response to injury.

New loci associated with kidney function and chronic kidney disease

VEGF inhibition and renal thrombotic microangiopathy

Proliferation and remodeling of the peritubular microcirculation after nephron reduction: association with the progression of renal lesions

Molecular mechanisms and clinical applications of angiogenesis

Oxygen sensing by HIF hydroxylases

Endothelial/pericyte interactions

Vascular endothelial growth factor induces nephrogenesis and vasculogenesis.

P2888

s00467-013-2430-y

P304

333-342

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00467-013-2430-Y

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

29

http://www.w3.org/2001/XMLSchema#string

P577

2013-03-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23475077

http://www.w3.org/2001/XMLSchema#string

P932

3726573

http://www.w3.org/2001/XMLSchema#string